An update into the pathophysiological role of HER2 in cancer: therapeutic implications A. OcañaA. Pandiella Editorial 21 October 2007 Pages: 543 - 544
Molecular markers in colorectal cancer: genetic bases for a customised treatment E. CasadoJ. De CastroM. González-Barón Educational Series 21 October 2007 Pages: 549 - 554
Apoptosis regulators as targets for cancer therapy J. L. Fernández-Luna Educational Series 21 October 2007 Pages: 555 - 562
Peptidomimetics in cancer chemotherapy C. AvendañoJ. C. Menéndez Educational Series 21 October 2007 Pages: 563 - 570
Effect of surgical resection of metastatic disease on immune tolerance to cancer. How a systemic disease could be controlled by a local therapy H. D. GonzálezJ. Figueras Review 21 October 2007 Pages: 571 - 577
Docetaxel-induced interstitial pneumonitis following non-small-cell lung cancer treatment C. GrandeM. J. VillanuevaJ. Casal Review 21 October 2007 Pages: 578 - 581
Recommendation of the scientific societies on the treatment of anaemia in cancer patients C. A. Rodríguez Sánchez Special Article 21 October 2007 Pages: 582 - 589
Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases C. ConillJ. BerenguerR. Vilella Research Articles 21 October 2007 Pages: 590 - 595
Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer M. MorenoJ. AristuR. Martínez-Monge Research Articles 21 October 2007 Pages: 596 - 602
Pancreatic metastases from ductal and lobular carcinomas of the breast A. Pérez OchoaF. Sáez HernáezM. García de Polavieja Carrasco Case Reports 21 October 2007 Pages: 603 - 605
Perianal metastases from lobular breast carcinoma J. M. BalibreaR. CanteroJ. L. Balibrea Case Reports 21 October 2007 Pages: 606 - 609